Sort

Search

17/07/2026 Modelling Hepatitis B virus related hospital discharges in Spain: ARIMAX based liver disease forecasting tool for hospital workload and mortality progression (Vol 21, e0329751, 2026)
Acosta, L, Soldevila, N, Torner, N, Avellon, A, Hernando, V, Borras, E, Martínez, A, Pericas, C, Rius, C, Godoy, P, Dominguez, A. Modelling Hepatitis B virus related hospital discharges in Spain: ARIMAX based liver disease forecasting tool for hospital workload and mortality progression (Vol 21, e0329751, 2026). PLoS One. 2026; 21(7)DOI:10.1371/journal.pone.0354253. PMID:. IF:2.600(Q2/4D).
16/07/2026 Real-world treatment patterns and outcomes in moderate-to-severe SLE: findings from the Spanish SPOCS cohort
Lozano-Rivas, N, Rúa-Figueroa, I, Freire-González, M, Turrión, A, Castellvi, I, Ajo, JB, Calvo-Alén, J, Ortego-Centeno, N, Díaz-Encarnación, M, Pego-Reigosa, JM, Ding, B, Galvez-Fernandez, M, Bahamontes-Rosa, N, Cervera, R. Real-world treatment patterns and outcomes in moderate-to-severe SLE: findings from the Spanish SPOCS cohort. Lupus Science & Medicine. 2026; 13(2)DOI:10.1136/lupus-2026-002054. PMID:42463277. IF:3.500(Q2/3D).
15/07/2026 International analysis of reimbursement rates and clinical benefit of genitourinary cancer drugs across Canada, France, England, Wales, Scotland, Spain, Italy, and Portugal
Tapia, JC, Gavira, J, Matthews, D, Santoni, M, Young, M, Blondel, L, Flippot, R, Frazer, R, Anguera, G, Maroto, P. International analysis of reimbursement rates and clinical benefit of genitourinary cancer drugs across Canada, France, England, Wales, Scotland, Spain, Italy, and Portugal. INTERNATIONAL JOURNAL OF CANCER. 2026; 159(2)DOI:10.1002/ijc.70379. PMID:41653082. IF:4.700(Q1/3D).
15/07/2026 A controlled-release mitochondrial protonophore attenuates early- and late-stage atheroprogression in mice
dos Santos, BG, Brisnovali, NF, Haney, C, Coven, M, Sebzevari, HL, Gaebel, L, Zhang, XB, Sun, JAT, Canfrán-Duque, A, Rotllan, N, Nasiri, A, Kahn, M, McAlpine, CS, Shulman, GI, Goedeke, L. A controlled-release mitochondrial protonophore attenuates early- and late-stage atheroprogression in mice. Science Translational Medicine. 2026; 18(858)DOI:10.1126/scitranslmed.adv1815. PMID:42455898. IF:14.600(Q1/1D).